Immediate Impact
7 standout
Citing Papers
LAG-3 as the third checkpoint inhibitor
2023 Standout
Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment
2022 Standout
Works of Rick Stanton being referenced
Abstract A124: Preclinical characterization of AB154, a fully humanized anti-TIGIT antibody, for use in combination therapies
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Rick Stanton | 22 | 7 | 8 | 7 | 4 | 33 | |
| Prasanna Channathodiyil | 24 | 5 | 3 | 5 | 4 | 36 | |
| Jasim Kada Benotmane | 32 | 16 | 4 | 8 | 5 | 41 | |
| Jan-Christian Hütter | 18 | 7 | 4 | 13 | 4 | 34 | |
| Galen Xing | 33 | 9 | 5 | 15 | 2 | 43 | |
| Mingxia Shi | 15 | 6 | 10 | 16 | 5 | 42 | |
| Marcia Regina Risso Gobato | 10 | 4 | 5 | 8 | 2 | 38 | |
| Yuan Chu | 18 | 7 | 4 | 4 | 2 | 28 | |
| Zishan Wu | 18 | 7 | 4 | 4 | 2 | 28 | |
| Cassidy Danyko | 23 | 4 | 3 | 3 | 4 | 31 | |
| Russell Kunes | 15 | 5 | 3 | 4 | 4 | 22 |
All Works
Loading papers...